학술논문
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
Document Type
Article
Author
Joseph-Mathurin, N.; McCullough, A.A.; Wang, Q.; Gordon, B.A.; Chen, C.D.; Flores, S.; Hassenstab, J.; Hobbs, D.A.; Hornbeck, R.C.; McKay, N.S.; Benzinger, T.L.S.; Llibre-Guerra, J.J.; Li, Y.; Fagan, A.M.; Snider, B.J.; McDade, E.; Perrin, R.J.; Bateman, R.J.; Clifford, D.B.; Hofmann, C.; Wojtowicz, J.; Park, E.; Wang, G.; Xiong, C.; Preboske, G.M.; Borowski, B.; Jack, C.R.; Aggarwal, N.T.; Berman, S.B.; Bird, T.D.; Black, S.E.; Masellis, M.; Brooks, W.S.; Chhatwal, J.P.; Clarnette, R.; Cruchaga, C.; Farlow, M.; Fox, N.C.; Mummery, C.J.; Gauthier, S.; Holdridge, K.C.; Mancini, M.; Yaari, R.; Honig, L.S.; Hsiung, G.-Y.R.; Jimenez-Velazquez, I.Z.; Jucker, M.; Klein, G.; Levin, J.; Ringman, J.M.; Shimada, H.; Suzuki, K.; Wallon, D.; Salloway, S.P.
Source
In: Annals of Neurology . (Annals of Neurology, November 2022, 92(5):729-744)
Subject
Language
English
ISSN
15318249
03645134
03645134